{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:46:48Z","timestamp":1782258408995,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012187","name":"St Vincent's Clinic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009860","name":"Ramaciotti Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.hlc.2026.03.054","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:07:51Z","timestamp":1778584071000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Rationale of the FICAPP Study: Frailty in Cardiac Amyloidosis: Profiling the Phenotype"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3470-6901","authenticated-orcid":false,"given":"Elyn","family":"Montgomery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Gorrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-9022","authenticated-orcid":false,"given":"Georgia","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5497-4298","authenticated-orcid":false,"given":"Kris","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julee","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-2825","authenticated-orcid":false,"given":"Peter S.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole K.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hlc.2026.03.054_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.hlc.2023.11.027","article-title":"2024 Australia & New Zealand Expert Consensus Statement on Cardiac Amyloidosis","volume":"33","author":"Bart","year":"2024","journal-title":"Heart Lung Circ"},{"issue":"6","key":"10.1016\/j.hlc.2026.03.054_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/bjh.16000","article-title":"The epidemiology of amyloidosis in Queensland, Australia","volume":"186","author":"Wisniowski","year":"2019","journal-title":"Brit J Haematol"},{"issue":"38","key":"10.1016\/j.hlc.2026.03.054_bib3","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2026.03.054_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcmg.2024.10.011","article-title":"The last decade in cardiac amyloidosis: Advances in understanding pathophysiology, diagnosis and quantification, prognosis, treatment strategies, and monitoring response","volume":"18","author":"Fontana","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hlc.2026.03.054_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40520-024-02750-6","article-title":"Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study","volume":"36","author":"Fumagalli","year":"2024","journal-title":"Aging Clin Exp Res"},{"issue":"20","key":"10.1016\/j.hlc.2026.03.054_bib6","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1182\/bloodadvances.2023010324","article-title":"Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis","volume":"7","author":"Gustine","year":"2023","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.hlc.2026.03.054_bib7","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2026.03.054_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The prevalence of frailty in heart failure: A systematic review and meta-analysis","volume":"236","author":"Denfeld","year":"2017","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2026.03.054_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.hlc.2025.01.012","article-title":"An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce","volume":"34","author":"McDonagh","year":"2025","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10.1016\/j.hlc.2026.03.054_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2023.09.013","article-title":"Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement","volume":"43","author":"Denfeld","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"23","key":"10.1016\/j.hlc.2026.03.054_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008251","article-title":"Impact of frailty on mortality and hospitalization in chronic heart failure: A systematic review and meta-analysis","volume":"7","author":"Yang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.hlc.2026.03.054_bib12","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.hlc.2026.03.054_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008105","article-title":"Prevalence and prognostic significance of frailty among patients with transthyretin amyloidosis cardiomyopathy","volume":"14","author":"Fine","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"Supplement_1","key":"10.1016\/j.hlc.2026.03.054_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.2084","article-title":"Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis","volume":"45","author":"Fumagalli","year":"2024","journal-title":"Eur Heart J"},{"issue":"6, Part 1","key":"10.1016\/j.hlc.2026.03.054_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101784","article-title":"Cardiac amyloidosis in older adults with a focus on frailty: JACC: Advances Expert Consensus","volume":"4","author":"Bart","year":"2025","journal-title":"JACC Adv"},{"issue":"6","key":"10.1016\/j.hlc.2026.03.054_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","article-title":"Frailty in older adults undergoing aortic valve replacement: The FRAILTY-AVR Study","volume":"70","author":"Afilalo","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2026.03.054_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/eurjcn\/zvac100","article-title":"Comparison of six frailty instruments in adults with heart failure: a prospective cohort pilot study","volume":"22","author":"McDonagh","year":"2022","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"10.1016\/j.hlc.2026.03.054_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0000000000000991","article-title":"The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation","volume":"100","author":"Jha","year":"2016","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.hlc.2026.03.054_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.healun.2016.04.008","article-title":"Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation","volume":"35","author":"Jha","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hlc.2026.03.054_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.hlc.2026.03.054_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jaccao.2025.01.018","article-title":"Clinical phenotype and prognostic significance of frailty in transthyretin cardiac amyloidosis","volume":"7","author":"Fumagalli","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"9","key":"10.1016\/j.hlc.2026.03.054_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.hlc.2026.03.054_bib23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/ejhf.3354","article-title":"Expansion of the National Amyloidosis Centre staging system to detect early mortality in transthyretin cardiac amyloidosis","volume":"26","author":"Nitsche","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.hlc.2026.03.054_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"10.1016\/j.hlc.2026.03.054_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033478","article-title":"Outcomes in cardiac transthyretin amyloidosis and association with New York Heart Association Class: Real-World Data","volume":"13","author":"M\u00fcller","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.hlc.2026.03.054_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2024.04.011","article-title":"Prognostic value of a 6-minute walk test in patients with transthyretin cardiac amyloidosis","volume":"84","author":"Ioannou","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hlc.2026.03.054_bib27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12603-009-0214-7","article-title":"Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status","volume":"13","author":"Kaiser","year":"2009","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"10.1016\/j.hlc.2026.03.054_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506129.2019.1698417","article-title":"Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype","volume":"27","author":"Driggin","year":"2020","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.hlc.2026.03.054_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1034\/j.1600-0447.2002.01248.x","article-title":"Cognitive-based measures screening for depression in the medically ill: the DMI-10 and the DMI-18","volume":"105","author":"Parker","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"10.1016\/j.hlc.2026.03.054_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008284","article-title":"Psychometric evaluation of the Kansas City Cardiomyopathy Questionnaire in men and women with heart failure","volume":"14","author":"Hejjaji","year":"2021","journal-title":"Circulation Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2026.03.054_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0962280206075304","article-title":"Multiple imputation: current perspectives","volume":"16","author":"Kenward","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.hlc.2026.03.054_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1536867X0500500204","article-title":"Multiple Imputation of Missing Values: Update","volume":"5","author":"Royston","year":"2005","journal-title":"Stata J"},{"key":"10.1016\/j.hlc.2026.03.054_bib33","series-title":"National Health and Medical Research Council","article-title":"National Statement on Ethical Conduct in Human Research","year":"2023"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:57:13Z","timestamp":1782255433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1443950626001836"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.03.054","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and Rationale of the FICAPP Study: Frailty in Cardiac Amyloidosis: Profiling the Phenotype","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}